Mobile Menu

Search Results

Search results for: Case Study

Ivermectin as a potential drug for treatment of COVID-19.

Numerous datasets from historic clinical trials are being reviewed in the hope that existing drugs, that have already been cleared […]

Real-World Evidence ONLINE

The transformation currently underway within pharma organizations is undoubtedly driving the need for, and use of, real-world data and evidence. […]

Interview with Anandbir Brar, Chief Executive Officer, Excelra

We recently interviewed Anandbir Brar, Chief Executive Officer of Excelra. Excelra is the lead sponsor for our D4 Global virtual event.  […]

Varenka Rodriguez DiBlasi, Boehringer Ingelheim: Computational biology approaches towards interrogating the tumor microenvironment

Varenka Rodriguez DiBlasi, Exploratory Bioinformatics Lab Head of Cancer Immunology at Boehringer Ingelheim, shared a case study at D4 USA […]

D4 Europe 2020

D4 Europe is packed with case studies, evidence and intelligence that you can take back to your organisation and impact […]

Meta-analysis of transcriptomic data from Huntington’s disease patients

Description of transcriptomic alterations in Huntington’s disease is essential for the identification of targets for biomedical studies and drug development. […]

Estimating IBD Treatment Effectiveness Using Electronic Health Records

Electronic health records (EHRs) are receiving growing attention as a potential source of real-world data. However, their suitability for evaluating […]

Reducing False Positive Drug Target Predictions

Target prediction with machine learning algorithms can help accelerate the identification of protein targets of hit molecules, limiting the number […]

Surrogate Endpoint Evaluation Methodology

Robust identification of clinical trial surrogate end points can help to accelerate the development of pharmacotherapies for diseases that are […]

AlzGPS: A Genome-Wide Positioning Systems Platform for Alzheimer’s Drug Discovery

Recent DNA/RNA sequencing and other multi-omics technologies have advanced our understanding of the biology and pathophysiology of Alzheimer’s disease. However, […]